Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosus.

Reynolds JA, Ray DW, Zeef LA, O'Neill T, Bruce IN, Alexander MY.

J Interferon Cytokine Res. 2014 May;34(5):404-12. doi: 10.1089/jir.2013.0016. Epub 2014 Jan 20.

2.

Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.

Kahlenberg JM, Thacker SG, Berthier CC, Cohen CD, Kretzler M, Kaplan MJ.

J Immunol. 2011 Dec 1;187(11):6143-56. doi: 10.4049/jimmunol.1101284. Epub 2011 Nov 4.

3.

IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus.

Buie JJ, Renaud LL, Muise-Helmericks R, Oates JC.

J Immunol. 2017 Sep 15;199(6):1979-1988. doi: 10.4049/jimmunol.1600108. Epub 2017 Aug 4.

PMID:
28779021
4.

The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.

Thacker SG, Berthier CC, Mattinzoli D, Rastaldi MP, Kretzler M, Kaplan MJ.

J Immunol. 2010 Oct 1;185(7):4457-69. doi: 10.4049/jimmunol.1001782. Epub 2010 Aug 30.

5.

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.

Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P, Zhang J, White B, Coyle AJ, Kiener PA, Jallal B.

Arthritis Rheum. 2009 Jun;60(6):1785-96. doi: 10.1002/art.24557.

6.

Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus.

Li J, Fu Q, Cui H, Qu B, Pan W, Shen N, Bao C.

Arthritis Rheum. 2011 Feb;63(2):492-502. doi: 10.1002/art.30165.

7.

Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.

Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S.

Arthritis Rheum. 2008 Mar;58(3):801-12. doi: 10.1002/art.23268.

8.

Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis.

Thacker SG, Zhao W, Smith CK, Luo W, Wang H, Vivekanandan-Giri A, Rabquer BJ, Koch AE, Pennathur S, Davidson A, Eitzman DT, Kaplan MJ.

Arthritis Rheum. 2012 Sep;64(9):2975-85. doi: 10.1002/art.34504.

9.

Interferon-alpha in systemic lupus erythematosus.

Crow MK, Kirou KA.

Curr Opin Rheumatol. 2004 Sep;16(5):541-7. Review.

PMID:
15314491
10.

Brief Report: Vitamin D Deficiency Is Associated With Endothelial Dysfunction and Increases Type I Interferon Gene Expression in a Murine Model of Systemic Lupus Erythematosus.

Reynolds JA, Rosenberg AZ, Smith CK, Sergeant JC, Rice GI, Briggs TA, Bruce IN, Kaplan MJ.

Arthritis Rheumatol. 2016 Dec;68(12):2929-2935. doi: 10.1002/art.39803.

11.

Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.

Morimoto AM, Flesher DT, Yang J, Wolslegel K, Wang X, Brady A, Abbas AR, Quarmby V, Wakshull E, Richardson B, Townsend MJ, Behrens TW.

Arthritis Rheum. 2011 Aug;63(8):2407-15. doi: 10.1002/art.30399.

12.

Anti-interferon alpha treatment in SLE.

Kirou KA, Gkrouzman E.

Clin Immunol. 2013 Sep;148(3):303-12. doi: 10.1016/j.clim.2013.02.013. Epub 2013 Mar 1. Review.

PMID:
23566912
13.

IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients.

Rodríguez-Carrio J, de Paz B, López P, Prado C, Alperi-López M, Ballina-García FJ, Suárez A.

PLoS One. 2014 Jan 21;9(1):e86069. doi: 10.1371/journal.pone.0086069. eCollection 2014.

14.

Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study.

Ducreux J, Houssiau FA, Vandepapelière P, Jorgensen C, Lazaro E, Spertini F, Colaone F, Roucairol C, Laborie M, Croughs T, Grouard-Vogel G, Lauwerys BR.

Rheumatology (Oxford). 2016 Oct;55(10):1901-5. doi: 10.1093/rheumatology/kew262. Epub 2016 Jun 28.

15.

Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus.

Mathian A, Amoura Z, Adam E, Colaone F, Hoekman MF, Dhellin O, Vandepapelière P, Haroche J, Piette JC, Lebon P, Grouard-Vogel G.

Ann Rheum Dis. 2011 Jun;70(6):1138-43. doi: 10.1136/ard.2010.141101. Epub 2011 Mar 9.

PMID:
21389044
16.

C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.

Lood C, Gullstrand B, Truedsson L, Olin AI, Alm GV, Rönnblom L, Sturfelt G, Eloranta ML, Bengtsson AA.

Arthritis Rheum. 2009 Oct;60(10):3081-90. doi: 10.1002/art.24852.

17.

Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis.

Denny MF, Thacker S, Mehta H, Somers EC, Dodick T, Barrat FJ, McCune WJ, Kaplan MJ.

Blood. 2007 Oct 15;110(8):2907-15. Epub 2007 Jul 16.

18.

Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-α production.

Zhan Y, Carrington EM, Ko HJ, Vikstrom IB, Oon S, Zhang JG, Vremec D, Brady JL, Bouillet P, Wu L, Huang DC, Wicks IP, Morand EF, Strasser A, Lew AM.

Arthritis Rheumatol. 2015 Mar;67(3):797-808. doi: 10.1002/art.38966.

19.

Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors.

Cates AM, Holden VI, Myers EM, Smith CK, Kaplan MJ, Kahlenberg JM.

Rheumatology (Oxford). 2015 Jun;54(6):1114-23. doi: 10.1093/rheumatology/keu431. Epub 2014 Nov 20.

20.

PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.

Wang Y, Ewart D, Crabtree JN, Yamamoto A, Baechler EC, Fazeli P, Peterson EJ.

Arthritis Rheumatol. 2015 Sep;67(9):2403-14. doi: 10.1002/art.39211.

Supplemental Content

Support Center